Introduction: Radical prostatectomy is the treatment of choice for localized prostate cancer. Minimally invasive surgery such as robotic-assisted laparoscopic radical prostatectomy (RALRP) is the new gold standard. RALRP has many advantages like visualisation of the surgical field, better instrument control, refined dissection and better assessment of high-risk pathological features. Detection of high-risk pathological features is important since they determine biochemical recurrence after prostatec tomy. This study evaluates oncological outcomes in patients undergoing RALRP. Materials and Methods: We retrospectively reviewed 88 patients who have undergone RALRP over 3 years (2018-2020). The appropriate data was statistically analysed and interpreted. Results: The mean patient age in our study was 68.3 years. Mean PSA was 18.5ng/ml. The majority of the patients in our study had the organ-confined disease (T2). 28% had extraprostatic extension (EPE), 20% showed seminal vesicle invasion. The right lateral margin was the most common positive surgical margin in our study. Pelvic lymph node dissection was done in 33 out of 88 patients out of which 6 patients showed lymph node metastasis. Conclusion: RALRP evolved as the most common treatment modality for prostatic cancers in recent years. Our study attempts to assess the pathological features in RALRP specimens.RALRP in our study provided a lesser positive surgical margin rate, improved visualization of apex, higher lymph node yield. This is in concordance with few studies published in the literature, which have compared RALRP with RRP.